10 / 102
L
azzoli
JK
104
R
ev
A
ssoc
M
ed
B
ras
2016; 62(2):101-105
TABLE 1
(Cont.) Permanently prohibited substances and methods (in- and out-of-competition).
Prohibited methods
M1. Manipulation of blood
and blood components
The following are prohibited:
1. The administration or reintroduction of any quantity of autologous, allogenic (homologous) or heterologous
blood, or red blood cell products of any origin into the circulatory system
2. Artificially enhancing the uptake, transport or delivery of oxygen, including efaproxiral (RSR13)
3. Any form of intravascular manipulation of the blood or blood components by physical or chemical means
M2. Chemical and physical
manipulation
The following are prohibited:
1. Tampering, or attempting to tamper, to alter the integrity and validity of samples collected during doping
control, including, but not limited to urine substitution and/or adulteration
2. Intravenous infusions and/or injections of more than 50 mL per 6 hour period except for those legitimately
received in the course of hospital admissions, surgical procedures or clinical investigations
M3. Gene doping
The following, with the potential to enhance sport performance, are prohibited:
1. The transfer of polymers of nucleic acids or nucleic acid analogues
2. The use of normal or genetically modified cells
Note: Only a few examples are cited; see the full list on WADA or ABCD websites.
TABLE 2
Substances and methods prohibited in-competition (In addition to the categories S0 to S5 and M1 to M3 defined
above, the following categories are prohibited in-competition).
Class
Sub-classes, examples, comments
S6. Stimulants
All stimulants, including all optical isomers, are prohibited, including:
a. Non-specified stimulants, e.g. amfepramone, amfetamine, fenproporex, methylamphetamine
b. Specified stimulants, e.g. sibutramine
Except for:
•
•
Clonidine
•
•
Imidazole derivatives for topical/ophthalmic use and those stimulants included in the 2016 Monitoring Program:
* Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, and synephrine: These substances are
included in the 2016 Monitoring Program, and are not considered prohibited substances
** Cathine: Prohibited when its concentration in urine is greater than 10 mcg/mL
*** Ephedrine and methylephedrine: Prohibited when the concentration of either in urine is greater than 10 mcg/mL
**** Epinephrine (adrenaline): Not prohibited in local administration, e.g. nasal, ophthalmologic, or co-administration
with local anaesthetic agents
***** Pseudoephedrine: Prohibited when its concentration in urine is greater than 150 mcg/mL
S7. Narcotics
The following are prohibited:
Buprenorphine, dextromoramide, diamorphine (heroin), fentanyl and its derivatives, hydromorphone, methadone,
morphine, oxycodone, oxymorphone, pentazocine and pethidine
S8. Cannabinoids
The following are prohibited:
•
•
Natural, e.g., cannabis, hashish and marijuana, or synthetic delta 9-tetrahydrocannabinol (THC)
•
•
Cannabimimetics, e.g., “Spice”, JWH-018, JWH-073, HU-210
S9. Glucocorticoids
All glucocorticoids are prohibited when administered by oral, intravenous, intramuscular or rectal routes
Note: Only a few examples are cited; see the full list on WADA or ABCD websites.